
Transactions: Healthcare
Filter


Initial public offering of Pronova BioPharma ASA (NO) — NOK 2.7 billion

Directed new share issue in Clavis Pharma ASA (NO) — NOK 154 million

Block trade of shares in Swedish Orphan Biovitrum (SE) — SEK 231 million

Private placement of equity in Phytera Inc. (US) — USD 7.6 million

Private placement of equity in Colifast Systems ASA (NO) — NOK 32 million

Private placement of equity in A+ Science Investment AB (SE) — SEK 71 million

Private placement of equity in Boule Diagnostics (SE) — SEK 44 million

Secondary placing of 965,000 shares in Meda AB (SE) — SEK 300 million

Divestment of AB Previa (SE) to Tryg i Danmark smba (DK) by Segulah (SE) — Amount not disclosed.

Rights issue in Oasmia Pharmaceutical (SE) — SEK 239 million
